Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma

Cell Cycle

Volumn 12, Issue 7, 2013, Pages 1058-1070

  Brait, Mariana ^a,b   Munari, Enrico ^a,c   LeBron, Cynthia ^a   Noordhuis, Maartje G ^a,d   Begum, Shahnaz ^c   Michailidi, Christina ^a   Gonzalez Roibon, Nilda ^c   Maldonado, Leonel ^a   Sen, Tanusree ^a   Guerrero Preston, Rafael ^a   Cope, Leslie ^d   Parrellaw, Paola ^e   Faziow, VitoMichele ^e,f   Ha, Patrick K ^a   Netto, George J ^c   Sidransky, David ^a   Hoque, Mohammad O ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^f UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Bladder cancer; Epigenetics; In vitro transformation; Smoking

Indexed keywords

CD146 ANTIGEN; CIGARETTE SMOKE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; RAC1 PROTEIN; TRANSCRIPTION FACTOR FKHR;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EPIGENETICS; EPITHELIUM CELL; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; SMOKING; TRANSITIONAL CELL CARCINOMA; TREATMENT DURATION; WESTERN BLOTTING;

EID: 84875910038     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.24050     Document Type: Article

References (70)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29; PMID:22237781; http://dx.doi.org/10.3322/caac.20138
2. Strope SA, Montie JE. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 2008; 180:31-7, discussion 37; PMID:18485400; http://dx.doi.org/10.1016/j.juro.2008.03.045
3. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol 2006; 3:327- 40; PMID:16763645; http://dx.doi.org/10.1038/ncpuro0510
4. Wang YH, Yeh SD, Wu MM, Liu CT, Shen CH, Shen KH, et al. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer. J Hazard Mater 2012; PMID:23009795; http://dx.doi.org/10. 1016/j. jhazmat.2012.08.056
5. Sozzi G, Pastorino U, Croce CM. MicroRNAs and lung cancer: from markers to targets. Cell Cycle 2011; 10:2045-6; PMID:21623159; http://dx.doi. org/10.4161/cc.10.13.15712
6. Marsit CJ, Karagas MR, Schned A, Kelsey KT. Carcinogen exposure and epigenetic silencing in bladder cancer. Ann N Y Acad Sci 2006; 1076:810- 21; PMID:17119258; http://dx.doi.org/10.1196/annals.1371.031
7. Enokida H, Nakagawa M. Epigenetics in bladder cancer. Int J Clin Oncol 2008; 13:298-307; PMID:18704629; http://dx.doi.org/10.1007/s10147- 008-0811-1
8. Wu X, Obata T, Khan Q, Highshaw RA, De Vere White R, Sweeney C. The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion. BJU Int 2004; 93:143-50; PMID:14678387; http://dx.doi.org/10.1111/j.1464-410X. 2004.04574.x
9. Onol FF, Demir A, Temiz Y, Yüksel M, Eren F, Türkeri LN. The inhibitory effect of vitamin E on cigarette smoke-induced oxidative damage to the rat urothelium: can it prevent transitional cell carcinoma? Urol Int 2007; 78:150-4; PMID:17293656; http://dx.doi. org/10.1159/000098074
10. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10:125-31; PMID:11219769
11. Hu YC, Yang ZH, Zhong KJ, Niu LJ, Pan XJ, Wu DC, et al. Alteration of transcriptional profile in human bronchial epithelial cells induced by cigarette smoke condensate. Toxicol Lett 2009; 190:23-31; PMID:19559774; http://dx.doi.org/10.1016/j.toxlet. 2009.06.860
12. Marsit CJ, Wiencke JK, Nelson HH, Kim DH, Hinds PW, Aldape K, et al. Alterations of 9p in squamous cell carcinoma and adenocarcinoma of the lung: association with smoking, TP53, and survival. Cancer Genet Cytogenet 2005; 162:115-21; PMID:16213358; http://dx.doi.org/10.1016/j.cancergencyto. 2005.04.001
13. Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, et al. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst 2006; 98:996-1004; PMID:16849682; http://dx.doi. org/10.1093/jnci/djj265
14. Kim WJ, Kim YJ. Epigenetic biomarkers in urothelial bladder cancer. Expert Rev Mol Diagn 2009; 9:259-69; PMID:19379084; http://dx.doi.org/10.1586/ erm.09.5
15. Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 2006; 27:112-6; PMID:15987713; http://dx.doi. org/10.1093/carcin/bgi172
16. Brait M, Begum S, Carvalho AL, Dasgupta S, Vettore AL, Czerniak B, et al. Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev 2008; 17:2786-94; PMID:18843024; http://dx.doi.org/10.1158/1055- 9965.EPI-08-0192
17. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001; 61:3419-24; PMID:11309302
18. Toyooka S, Suzuki M, Tsuda T, Toyooka KO, Maruyama R, Tsukuda K, et al. Dose effect of smoking on aberrant methylation in non-small cell lung cancers. Int J Cancer 2004; 110:462-4; PMID:15095316; http://dx.doi.org/10.1002/ijc.20125
19. Toyooka S, Maruyama R, Toyooka KO, McLerran D, Feng Z, Fukuyama Y, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer 2003; 103:153-60; PMID:12455028; http://dx.doi. org/10.1002/ijc.10787
20. Marsit CJ, Houseman EA, Schned AR, Karagas MR, Kelsey KT. Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis 2007; 28:1745-51; PMID:17522068; http://dx.doi.org/10.1093/carcin/bgm116
21. Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 1997; 105(Suppl 4):875-82; PMID:9255574
22. Carp H, Janoff A. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastaseinhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 1978; 118:617-21; PMID:101105
23. Massey E, Aufderheide M, Koch W, Lodding H, Pohlmann G, Windt H, et al. Micronucleus induction in V79 cells after direct exposure to whole cigarette smoke. Mutagenesis 1998; 13:145-9; PMID:9568586; http://dx.doi.org/10.1093/ mutage/13.2.145
24. Christian BJ, Loretz LJ, Oberley TD, Reznikoff CA. Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res 1987; 47:6066-73; PMID:2822239
25. Reznikoff CA, Loretz LJ, Christian BJ, Wu SQ, Meisner LF. Neoplastic transformation of SV40- immortalized human urinary tract epithelial cells by in vitro exposure to 3-methylcholanthrene. Carcinogenesis 1988; 9:1427-36; PMID:2841047; http://dx.doi. org/10.1093/carcin/9.8.1427
26. Cordon-Cardo C. Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol Suppl 2008:154-65; PMID:18815930; http://dx.doi.org/10.1080/03008880802291915
27. Zhang ZF, Kurtz RC, Marshall JR. Cigarette smoking and esophageal and gastric cardia adenocarcinoma. J Natl Cancer Inst 1997; 89:1247-9; PMID:9293909; http://dx.doi.org/10.1093/jnci/89.17.1247
28. Wolff EM, Liang G, Cortez CC, Tsai YC, Castelao JE, Cortessis VK, et al. RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Res 2008; 68:6208-14; PMID:18676844; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6616
29. Platt FM, Hurst CD, Taylor CF, Gregory WM, Harnden P, Knowles MA. Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer. Clin Cancer Res 2009; 15:6008-17; PMID:19789314; http://dx.doi.org/10. 1158/1078- 0432.CCR-09-0898
30. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003; 111:81-90; PMID:12511591
31. Ho YS, Chen CH, Wang YJ, Pestell RG, Albanese C, Chen RJ, et al. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol 2005; 205:133-48; PMID:15893541; http://dx.doi. org/10.1016/j.taap.2004.09.019
32. Jin Q, Menter DG, Mao L, Hong WK, Lee HY. Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure. Carcinogenesis 2008; 29:1614-22; PMID:18635526; http://dx.doi. org/10.1093/carcin/bgm234
33. Parsanejad R, Fields WR, Morgan WT, Bombick BR, Doolittle DJ. The time course of expression of genes involved in specific pathways in normal human bronchial epithelial cells following exposure to cigarette smoke. Exp Lung Res 2008; 34:513-30; PMID:18850377; http://dx.doi.org/10.1080/01902140802271826
34. Qu MY, Luo BL, Chen HM, Feng JT, Gu QH. Effects of secretory leukocyte protease inhibitor on expression of inflammation mediators in normal human bronchial epithelial cells induced by cigarette smoke extract. 2008; 31:352-5; PMID:18953959
35. Wu JP, Chang LW, Yao HT, Chang H, Tsai HT, Tsai MH, et al. Involvement of oxidative stress and activation of aryl hydrocarbon receptor in elevation of CYP1A1 expression and activity in lung cells and tissues by arsenic: an in vitro and in vivo study. Toxicol Sci 2009; 107:385-93; PMID:19033395; http://dx.doi. org/10.1093/toxsci/kfn239
36. Walsh KM, Amos CI, Wenzlaff AS, Gorlov IP, Sison JD, Wu X, et al. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans. Oncotarget 2012; 3:1428-38; PMID:23232035
37. Crallan RA, Georgopoulos NT, Southgate J. Experimental models of human bladder carcinogenesis. Carcinogenesis 2006; 27:374-81; PMID:16287878; http://dx.doi.org/10.1093/carcin/bgi266
38. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a metaanalysis of epidemiologic studies. Cancer 2000; 89:630-9; PMID:10931463; http://dx.doi. org/10.1002/1097-0142(20000801)89:3<630::AIDCNCR19> 3.0.CO;2-Q
39. Oka N, Tanimoto S, Taue R, Nakatsuji H, Kishimoto T, Izaki H, et al. Role of phosphatidylinositol-3 kinase/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Sci 2006; 97:1093-8; PMID:16984382; http://dx.doi.org/10.1111/j.1349-7006.2006. 00294.x
40. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999; 96:4240-5; PMID:10200246; http://dx.doi.org/10.1073/ pnas.96.8.4240
41. Simpson L, Parsons R. PTEN: life as a tumor suppressor. Exp Cell Res 2001; 264:29-41; PMID:11237521; http://dx.doi.org/10.1006/excr.2000.5130
42. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 1999; 96:6199- 204; PMID:10339565; http://dx.doi.org/10.1073/pnas.96.11.6199
43. Backman SA, Stambolic V, Suzuki A, Haight J, Elia A, Pretorius J, et al. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 2001; 29:396-403; PMID:11726926; http://dx.doi. org/10.1038/ng782
44. Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007; 128:157- 70; PMID:17218262; http://dx.doi.org/10.1016/j. cell.2006.11.042
45. Girard L, Zöchbauer-Müller S, Virmani AK, Gazdar AF, Minna JD. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 2000; 60:4894- 906; PMID:10987304
46. Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL, et al. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 2005; 65:9347-54; PMID:16230397; http://dx.doi. org/10.1158/0008-5472.CAN-05- 1647
47. Bakkar AA, Wallerand H, Radvanyi F, Lahaye JB, Pissard S, Lecerf L, et al. FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Res 2003; 63:8108- 12; PMID:14678961
48. Cote RJ, Chatterjee SJ. Molecular determinants of outcome in bladder cancer. Cancer J Sci Am 1999; 5:2-15; PMID:10188054
49. Shariat SF, Bolenz C, Karakiewicz PI, Fradet Y, Ashfaq R, Bastian PJ, et al. p53 expression in patients with advanced urothelial cancer of the urinary bladder. BJU Int 2010; 105:489-95; PMID:19659466; http://dx.doi.org/10.1111/j. 1464-410X.2009.08742.x
50. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004; 304:554; PMID:15016963; http://dx.doi. org/10.1126/science.1096502
51. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006; 7:606-19; PMID:16847462; http://dx.doi.org/10.1038/nrg1879
52. Aaltonen V, Koivunen J, Laato M, Peltonen J. Heterogeneity of cellular proliferation within transitional cell carcinoma: correlation of protein kinase C alpha/betaI expression and activity. J Histochem Cytochem 2006; 54:795-806; PMID:16517978; http://dx.doi.org/10.1369/jhc.5A6839.2006
53. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, et al. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 1996; 379:91-6; PMID:8538749; http://dx.doi. org/10.1038/379091a0
54. McDonald PC, Fielding AB, Dedhar S. Integrin-linked kinase-essential roles in physiology and cancer biology. J Cell Sci 2008; 121:3121-32; PMID:18799788; http://dx.doi.org/10.1242/jcs.017996
55. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, et al. Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res 2001; 7:1987-91; PMID:11448915
56. Bravou V, Klironomos G, Papadaki E, Stefanou D, Varakis J. Integrin-linked kinase (ILK) expression in human colon cancer. Br J Cancer 2003; 89:2340- 1; PMID:14676816; http://dx.doi.org/10.1038/sj.bjc.6601482
57. Takanami I. Increased expression of integrin-linked kinase is associated with shorter survival in nonsmall cell lung cancer. BMC Cancer 2005; 5:1; PMID:15631637; http://dx.doi.org/10.1186/1471- 2407-5-1
58. Matsui Y, Assi K, Ogawa O, Raven PA, Dedhar S, Gleave ME, et al. The importance of integrin-linked kinase in the regulation of bladder cancer invasion. Int J Cancer 2012; 130:521-31; PMID:21351095; http://dx.doi.org/10. 1002/ijc.26008
59. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008; 27:7274-84; PMID:18806826; http://dx.doi. org/10.1038/onc.2008.333
60. Chen D, Zhang Y, Zhang X, Li J, Han B, Liu S, et al. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes. Acta Histochem 2013; 115:128- 36; PMID:22683084; http://dx.doi.org/10.1016/j. acthis.2012.05.004
61. Miki H, Miura K, Takenawa T. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J 1996; 15:5326-35; PMID:8895577
62. Stradal TE, Rottner K, Disanza A, Confalonieri S, Innocenti M, Scita G. Regulation of actin dynamics by WASP and WAVE family proteins. Trends Cell Biol 2004; 14:303-11; PMID:15183187; http://dx.doi. org/10.1016/j.tcb.2004.04.007
63. Lorenz M, Yamaguchi H, Wang Y, Singer RH, Condeelis J. Imaging sites of N-wasp activity in lamellipodia and invadopodia of carcinoma cells. Curr Biol 2004; 14:697-703; PMID:15084285; http://dx.doi. org/10.1016/j.cub.2004.04.008
64. Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos ET, Condeelis J. N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci 2012; 125:724-34; PMID:22389406; http://dx.doi. org/10.1242/jcs.092726
65. Gomes AR, Brosens JJ, Lam EW. Resist or die: FOXO transcription factors determine the cellular response to chemotherapy. Cell Cycle 2008; 7:3133- 6; PMID:18927504; http://dx.doi.org/10.4161/cc.7.20.6920
66. Derks S, Bosch LJ, Niessen HE, Moerkerk PT, van den Bosch SM, Carvalho B, et al. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3- mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Carcinogenesis 2009; 30:1041-8; PMID:19329758; http://dx.doi.org/10.1093/carcin/bgp073
67. Zhao G, Qin Q, Zhang J, Liu Y, Deng S, Liu L, et al. Hypermethylation of HIC1 Promoter and Aberrant Expression of HIC1/SIRT1 Might Contribute to the Carcinogenesis of Pancreatic Cancer. Ann Surg Oncol 2012; PMID:22552606; http://dx.doi.org/10.1245/s10434-012-2364-9
68. Kao C, Huang J, Wu SQ, Hauser P, Reznikoff CA. Role of SV40 T antigen binding to pRB and p53 in multistep transformation in vitro of human uroepithelial cells. Carcinogenesis 1993; 14:2297-302; PMID:8242858; http://dx.doi.org/10.1093/carcin/14.11.2297
69. Hoque MO, Begum S, Brait M, Jeronimo C, Zahurak M, Ostrow KL, et al. Tissue inhibitor of metalloproteinases- 3 promoter methylation is an independent prognostic factor for bladder cancer. J Urol 2008; 179:743-7; PMID:18082200; http://dx.doi. org/10.1016/j.juro.2007.09.019
70. Castillo-Pichardo L, Martínez-Montemayor MM, Martínez JE, Wall KM, Cubano LA, Dharmawardhane S. Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin Exp Metastasis 2009; 26:505-16; PMID:19294520; http://dx.doi.org/10.1007/s10585-009-9250-2